HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), a global ...
Dr. Reddy’s Laboratories SA, Switzerland completed its acquisition of Haleon’s global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy category outside of the United States, ...
Dr Reddy’s Laboratories (RDY) has released an update. Dr. Reddy’s Laboratories Ltd. has completed the acquisition of Haleon plc’s Nicotinell brand and related NRT products, expanding its consumer ...
Dr Reddy's Laboratories, an Indian pharmaceutical group, is in talks to buy Nicotinell, the anti-smoking aid, from its FTSE-100 parent company. Sky News has learnt that Hyderabad-based Dr Reddy's has ...
Dubai, October 17, 2004: Novartis Consumer Health has today announced that Awkaf has endorsed the usage of its nicotine replacement therapy (NRT) product, Nicotinell, during Ramadan. Approval has been ...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ...
Add Yahoo as a preferred source to see more of our stories on Google. Dr Reddy's Laboratories, an Indian pharmaceutical group, is in talks to buy Nicotinell, the anti-smoking aid, from its FTSE-100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results